GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
Key figures
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $30.5B | +5.5% |
| Gross profit | $24.2B | +6.9% |
| Operating income | −$2.5B | — |
| Net income | −$3.2B | — |
| EPS | −$2.67 | — |
| Free cash flow | $12.9B | +38.1% |
Gilead Sciences, Inc.
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $30.5B | +5.5% |
| Gross profit | $24.2B | +6.9% |
| Operating income | −$2.5B | — |
| Net income | −$3.2B | — |
| EPS | −$2.67 | — |
| Free cash flow | $12.9B | +38.1% |